Technical Analysis for BGNE - BeiGene, Ltd.

Grade Last Price % Change Price Change
grade D 157.32 0.12% 0.19
BGNE closed up 0.12 percent on Friday, August 17, 2018, on 40 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical BGNE trend table...

Date Alert Name Type % Chg
Aug 17 Lower Bollinger Band Walk Weakness 0.00%
Aug 17 Multiple of Ten Bearish Other 0.00%
Aug 17 Oversold Stochastic Weakness 0.00%
Aug 16 NR7 Range Contraction 0.12%
Aug 16 Doji - Bullish? Reversal 0.12%
Aug 16 Lower Bollinger Band Walk Weakness 0.12%
Aug 16 Multiple of Ten Bearish Other 0.12%
Aug 16 Lower Bollinger Band Touch Weakness 0.12%
Aug 16 Oversold Stochastic Weakness 0.12%
Aug 15 180 Bearish Setup Bearish Swing Setup -0.23%

Older signals for BGNE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People's Republic of China. The company's clinical stage drug candidates include BGB-3111, a small molecule BTK inhibitor for the treatment of various lymphomas; BGB-283, a small molecule RAF dimer inhibitor to treat cancers with aberrations in the mitogen-activated protein kinase pathway, including BRAF mutations and KRAS/NRAS gene mutations; BGB-290, an inhibitor of PARP1 and PARP2 for the treatment of homologous recombination deficient cancers; and BGB-A317, a humanized monoclonal antibody for solid-organ and blood-borne cancers. Its preclinical programs comprise a PD-L1 monoclonal antibody, an additional RAF dimer inhibitor, a TIM-3 cell surface protein monoclonal antibody, and a BTK inhibitor for non-oncology indications. The company was founded in 2010 and is based in Camana Bay, Cayman Islands.
Is BGNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 220.1
52 Week Low 65.67
Average Volume 333,977
200-Day Moving Average 145.3678
50-Day Moving Average 169.586
20-Day Moving Average 171.4525
10-Day Moving Average 166.038
Average True Range 8.1716
ADX 17.68
+DI 15.4842
-DI 26.0233
Chandelier Exit (Long, 3 ATRs ) 170.0452
Chandelier Exit (Short, 3 ATRs ) 179.5248
Upper Bollinger Band 189.0367
Lower Bollinger Band 153.8683
Percent B (%b) 0.1
BandWidth 20.512037
MACD Line -3.2559
MACD Signal Line -1.0534
MACD Histogram -2.2025
Fundamentals Value
Market Cap 6.27 Billion
Num Shares 39.8 Million
EPS -4.97
Price-to-Earnings (P/E) Ratio -31.65
Price-to-Sales 0.00
Price-to-Book 12.46
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 166.86
Resistance 3 (R3) 167.32 164.60 165.27
Resistance 2 (R2) 164.60 162.17 164.37 164.74
Resistance 1 (R1) 160.96 160.67 159.60 160.50 164.21
Pivot Point 158.24 158.24 157.56 158.01 158.24
Support 1 (S1) 154.60 155.81 153.24 154.14 150.43
Support 2 (S2) 151.88 154.31 151.65 149.90
Support 3 (S3) 148.24 151.88 149.37
Support 4 (S4) 147.78